Treatment of aplastic anemia with antithymocyte globulin, Lymphoser Berna

S. Kojima, K. Matsumoto, K. Kato, T. Matsuyama, T. Sugihara, S. Minami, Y. Kodera, Y. Miyajima, I. Katayama, K. Horibe

研究成果: Contribution to journalArticle査読


Twenty-four patients with aplastic anemia (19 severe: 5 moderate) were treated with combined immunosuppression consisting of antithymocyte globulin (ATG: Lymphoser Berna, Swiss Serum and Vaccine Institute Berne) and high-dose methylprednisolone. Danazol or meptiostane was administered concurrently for at least 3 months. Three batches of ATG were used, two were not absorbed with thrombocytes and one was absorbed with thrombocytes for the prevention of thrombocytopenia. Nine of 20 evaluable patient (45%) had sustained improvement in hematopoiesis within 3 months of treatment. Nine of 14 patients (64%) showed a response to ATG without thrombocyte absorption, on the other hand, none of 6 patients responded to ATG with thrombocyte absorption. By life table analysis, the 3 year probability of survival was 81 +/- 27% after the combined immunosuppressive therapy. These results indicated that ATG therapy was very effective in Japanese patients with aplastic anemia.

ジャーナル[Rinshō ketsueki] The Japanese journal of clinical hematology
出版ステータス出版済み - 7 1993

All Science Journal Classification (ASJC) codes

  • 医学(全般)


「Treatment of aplastic anemia with antithymocyte globulin, Lymphoser Berna」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。